Legal Battles Intensify: Pharmaceutical Manufacturers' Lawsuits Targeting Compounding Pharmacies
Analyzing the patent and trademark challenges faced by 503A compounding pharmacies.
Source: pharmacytimes.com
Martham Rumore News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Martham Rumore. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Martham Rumore Today - Breaking & Trending Today
Nonprescription Drug and Cosmetic Regulatory Overhaul: What Pharmacists Need to Know
The crucial role of self-care pharmacy practice requires that pharmacists develop a robust understanding of the implications of the current and proposed regulatory changes for nonprescription drugs.
Source: pharmacytimes.com
Updates on 503A Compounding: The Impact of Drug Shortages
The FDA’s temporary Guidance for 503A compounding of shortage drugs was meant to be temporary and withdrawn once COVID-19 ended.
Source: pharmacytimes.com
Updates on 503A Compounding: Legal and Regulatory Developments
Part 1 of this 2-part series examines USP <797> and <795> revisions for sterile and nonsterile compounding, veterinary compounding, FDA inspections of 503A pharmacies, and the interstate distribution of compounded prescriptions post Wellness Pharmacy v. FDA.
Source: pharmacytimes.com